NVIM
NVO

New Vernon Investment Management’s Novo Nordisk NVO Stock Holding History

New Vernon Investment Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$334K Hold
9,100
– – 0.36% 39
2025
Q4 		$463K Hold
9,100
– – 0.45% 37
2025
Q3 		$505K Buy
+9,100
New +$533K 0.47% 39

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

New Vernon Investment Management's NVO Position: Q1 2026 in Review

New Vernon Investment Management held its Novo Nordisk (NVO) position steady in Q1 2026 at 9,100 shares worth $334K. The position accounts for 0.36% of the portfolio, ranked #39.

New Vernon Investment Management first reported a position in NVO in Q3 2025 and has held it in 3 quarters since. The position peaked at $505K in Q3 2025. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • New Vernon Investment Management held 9,100 shares of Novo Nordisk worth $334K as of Q1 2026.
  • New Vernon Investment Management left its Novo Nordisk share count unchanged in Q1 2026.
  • Novo Nordisk made up 0.36% of New Vernon Investment Management's portfolio in Q1 2026, its #39 holding.
  • New Vernon Investment Management first reported a position in Novo Nordisk in Q3 2025 and has held it in 3 quarters since.
  • New Vernon Investment Management's Novo Nordisk position peaked at $505K in Q3 2025.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on New Vernon Investment Management's 13F filing for Q1 2026, filed 15 May 2026.